- NEWS AND VIEWS
A next-generation inhalable dry powder COVID vaccine
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 624, 532-534 (2023)
doi: https://doi.org/10.1038/d41586-023-03557-7
References
Ye, T. et al. Nature 624, 630–638 (2023).
Marks, P. W., Gruppuso, P. A. & Adashi, E. Y. JAMA 329, 19–20 (2023).
Lavelle, E. C. & Ward, R. W. Nature Rev. Immunol. 22, 236–250 (2022).
Afkhami, S., Kang, A., Jeyanathan, V., Xing, Z. & Jeyanathan, M. Curr. Opin. Virol. 61, 101334 (2023).
Cahn, D., Amosu, M., Maisel, K. & Duncan, G. A. Nature Rev. Bioeng. 1, 83–84 (2023).
van Ginkel, F. W., Jackson, R. J., Yuki, Y. & McGhee, J. R. J. Immunol. 165, 4778–4782 (2000).
Damjanovic, D., Zhang, X., Mu, J., Medina, M. F. & Xing, Z. Genet. Vaccines Ther. 6, 5 (2008).
Jeyanathan, M. et al. JCI Insight 7, e155655 (2022).
Li, J.-X. et al. Lancet 23, 1143–1152 (2023).
Jeyanathan, M., Afkhami, S., Kang, A., & Xing, Z. Curr. Opin. Immunol. 84, 102370 (2023).
Yao, Y. et al. Cell 175, 1634–1650 (2018).
Afkhami, S. et al. Cell 185, 895–915 (2022).
Jeyanathan, M. et al. Nature Rev. Immunol. 20, 615–632 (2020).
Antoun, E., Peng, Y. & Dong T. Nature Immunol. 24, 1594–1596 (2023).
Competing Interests
The authors declare no competing interests.